Table 1 Clinicopathologic features in the 39 patients with RGC
Age, years old | |
Median (IQR) | 75 (71–79) |
Gender | |
Male | 34 (87.2%) |
Female | 5 (12.8%) |
PNI | |
Median (IQR) | 47.3 (44.6–51.6) |
Charlson Comorbidity Index | |
Median (IQR) | 0 (0–2) |
Cause of initial gastrectomy | |
Benign | 20 (51.3%) |
Malignant | 19 (48.7%) |
Reconstruction in initial gastrectomy | |
Billroth-I | 20 (51.3%) |
Others | 19 (48.7%) |
Interval, years | |
Median (IQR) | 28 (14.0–47.0) |
Neoadjuvant chemotherapy | |
− | 38 (97.4%) |
+ | 1 (2.6%) |
pT | |
1 | 15 (38.4%) |
2 | 4 (10.3%) |
3 | 11 (28.2%) |
4 | 9 (23.1%) |
pN | |
0 | 30 (76.9%) |
1 | 6 (15.4%) |
2 | 3 (7.7%) |
pStage | |
I | 19 (48.7%) |
II | 13 (33.3%) |
III | 7 (18.0%) |
Histological type | |
Differentiated type | 25 (64.1%) |
Undifferentiated type | 13 (33.3%) |
Unknown | 1 (2.6%) |
Lymphatic invasion | |
− | 12 (30.8%) |
+ | 27 (69.2%) |
Venous invasion | |
− | 13 (33.3%) |
+ | 26 (66.7%) |
Tumor location | |
Anastomosis | 17 (43.6%) |
Others | 22 (56.4%) |
Clavien-Dindo grade | |
0 or I | 20 (51.3%) |
II | 13 (33.3%) |
III | 3 (7.7%) |
IV | 3 (7.7%) |
Adjacent organ resections | |
− | 34 |
+ | 5 |
Follow-up period, years | |
Median (IQR) | 4 (2.1–5.8) |
Adjuvant chemotherapy | |
− | 32 (82.1%) |
+ | 7 (17.9%) |
Recurrence | |
− | 30 (76.9%) |
+ | 9 (23.1%) |